These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 30217421)
1. The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria. Bertaglia E; Reggiani A; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Arena G; Marini M; Ricciardi G; Badolati S; Spotti A; Solimene F; Ferraro A; Migliore F; Botto GL; Malacrida M; Stabile G Int J Cardiol; 2018 Dec; 273():162-167. PubMed ID: 30217421 [TBL] [Abstract][Full Text] [Related]
2. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy. Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405 [TBL] [Abstract][Full Text] [Related]
3. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure. Lund LH; Svennblad B; Dahlström U; Ståhlberg M Eur J Heart Fail; 2018 Apr; 20(4):769-777. PubMed ID: 28949083 [TBL] [Abstract][Full Text] [Related]
4. Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II. Normand C; Linde C; Blomström-Lundqvist C; Stellbrink C; Gasparini M; Anker SD; Plummer C; Sarigul NU; Papiashvili G; Iovev S; Dickstein K Europace; 2020 Jun; 22(6):932-938. PubMed ID: 32330937 [TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866 [TBL] [Abstract][Full Text] [Related]
6. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Dickstein K; Normand C; Auricchio A; Bogale N; Cleland JG; Gitt AK; Stellbrink C; Anker SD; Filippatos G; Gasparini M; Hindricks G; Blomström Lundqvist C; Ponikowski P; Ruschitzka F; Botto GL; Bulava A; Duray G; Israel C; Leclercq C; Margitfalvi P; Cano Ó; Plummer C; Sarigul NU; Sterlinski M; Linde C Eur J Heart Fail; 2018 Jun; 20(6):1039-1051. PubMed ID: 29457358 [TBL] [Abstract][Full Text] [Related]
7. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II. Gatti P; Linde C; Benson L; Thorvaldsen T; Normand C; Savarese G; Dahlström U; Maggioni AP; Dickstein K; Lund LH Eur Heart J Qual Care Clin Outcomes; 2023 Dec; 9(8):741-748. PubMed ID: 37076773 [TBL] [Abstract][Full Text] [Related]
8. [The new ESC Guidelines for acute and chronic heart failure 2016]. Oeing CU; Tschöpe C; Pieske B Herz; 2016 Dec; 41(8):655-663. PubMed ID: 27858115 [TBL] [Abstract][Full Text] [Related]
9. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports]. Silber S; Richartz BM; Brilmayer M; Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646 [TBL] [Abstract][Full Text] [Related]
10. CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis. Ranganathan D; Sharif Z; Murphy T; Mahon N; Sheahan CR; Normand C; Linde C; Dickstein K; Sheahan R Ir J Med Sci; 2020 Aug; 189(3):895-905. PubMed ID: 31981072 [TBL] [Abstract][Full Text] [Related]
11. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR; Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828 [TBL] [Abstract][Full Text] [Related]
12. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial. Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807 [TBL] [Abstract][Full Text] [Related]
13. [Acute and chronic heart failure in light of the new ESC guidelines]. Pöss J; Link A; Böhm M Herz; 2013 Dec; 38(8):812-20. PubMed ID: 24146139 [TBL] [Abstract][Full Text] [Related]
14. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
15. Fifteen-Year Differences in Indications for Cardiac Resynchronization Therapy in International Guidelines-Insights from the Heart Failure Registries of the European Society of Cardiology. Tymińska A; Ozierański K; Brociek E; Kapłon-Cieślicka A; Balsam P; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Opolski G; Grabowski M J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683625 [TBL] [Abstract][Full Text] [Related]
16. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. Lyons KJ; Ezekowitz JA; Liang L; Heidenreich PA; Yancy CW; DeVore AD; Hernandez AF; Fonarow GC JACC Heart Fail; 2017 May; 5(5):388-392. PubMed ID: 28449799 [TBL] [Abstract][Full Text] [Related]
17. [Indication for CRT]. Schlösser M; Stellbrink C Herzschrittmacherther Elektrophysiol; 2009 Sep; 20(3):103-8. PubMed ID: 19730926 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of true left bundle branch block in current practice of cardiac resynchronization therapy implantation. Migliore F; Baritussio A; Stabile G; Reggiani A; D'Onofrio A; Palmisano P; Caico SI; De Simone A; Marini M; Pecora D; Padeletti L; Botto GL; Malacrida M; Bertaglia E J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):462-8. PubMed ID: 26258725 [TBL] [Abstract][Full Text] [Related]
19. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754 [TBL] [Abstract][Full Text] [Related]
20. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L; Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]